Answers are grounded in this paper and cite their sources.
Demonstrates a high-throughput imaging assay to functionally profile rare LDLR variants, distinguishing disruptive from silent mutations to aid familial hypercholesterolemia diagnosis.
Familial hypercholesterolemia (FH) is the most common inherited life-threatening disorder of lipid metabolism. Early diagnosis and treatment are the key to reduce the cumulative life-long cardiovascular burden of patients with FH. The high number of LDLR variants described as variants of unknown significance is the largest obstacle to achieve a definitive FH diagnosis. This study established a time- and cost-effective high-throughput cell-based assay to functionally profile LDLR variants, which allowed us to discriminate disruptive rare variants from silent ones. This work generated a valuable resource for systematic functional characterization of LDLR variants solving 1 of the major issues to achieve a definitive FH diagnosis.
No takes yet. Share an insight, caveat, or question.
Graça et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: